Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2005
Expression and localization of mRNAs for matrix metalloproteinases and their inhibitors in mixed bronchioloalveolar carcinomas with invasive componentsNaoki Kanomata, Rie Nakahara, Tatsuya Oda, et al.Breast Cancer (Tokyo, Japan)|June 13, 2012
Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy aloneJunichi Kurebayashi, Naoki Kanomata, Toshiro Shimo, et al.Breast Cancer (Tokyo, Japan)|May 29, 2009
Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesionsTakuya Moriya, Naoki Kanomata, Yuji Kozuka, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2010
Significance of microscopic invasion into hilar peribronchovascular soft tissue in resection specimens of primary non-small cell lung cancerYasuhiro Sakai, Chiho Ohbayashi, Naoki Kanomata, et al.Japanese Journal of Radiology|January 10, 2023
The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccinationKiyoko Mukai, Hiroko Tsunoda, Ryosuke Imai, et al.Cancer Research|May 3, 2003
Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient miceHiroyuki Yonou, Naoki Kanomata, Masato Goya, et al.Cancer|November 24, 2004
Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cellsYoshimasa Maniwa, Masahiro Yoshimura, Vladimir P Bermudez, et al.Cancer|January 31, 2006
His239Arg SNP of HRAD9 is associated with lung adenocarcinomaYoshimasa Maniwa, Masahiro Yoshimura, Vladimir P Bermudez, et al.Journal of Clinical Pathology|April 1, 2016
Two progressive pathways of microinvasive carcinoma: low-grade luminal pathway and high-grade HER2 pathway based on high tumour-infiltrating lymphocytesMichi Morita, Rin Yamaguchi, Maki Tanaka, et al.Medical Molecular Morphology|July 1, 2011
Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinomaNaoto Kuroda, Naoki Kanomata, Tadanori Yamaguchi, et al.Pageof 10